Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ALB

Is Wall Street Bullish or Bearish on Albemarle Stock?

Albemarle has notably outperformed the broader market over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Barchart

Albemarle’s Blowout Quarter Shows Why Lithium Still Matters

Albemarle's Q2 2026 earnings beat estimates with adjusted EPS up over 3,300% year over year and 30% revenue growth, driven by higher lithium prices and rising global demand.

MarketBeat

Earnings Preview: What To Expect From Albemarle's Report

Albemarle is set to announce its second-quarter earnings soon, and Wall Street expects a significant surge in its profits.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

How Is Albemarle's Stock Performance Compared to Other Material Stocks?

Albemarle has underperformed its industry peers recently, yet analysts remain moderately optimistic about the stock’s prospects.

Barchart

Albemarle Stock In Focus as Citi Issues Bullish Note on Lithium Stocks

Albemarle stock is in focus as Citi issues a bullish note on the lithium sector. Here’s why the firm expects ALB shares to rally further in 2026.

Barchart

Are Wall Street Analysts Bullish on Albemarle Corporation Stock?

Albemarle Corporation has rallied the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.

Barchart

Albemarle’s Quarterly Earnings Preview: What You Need to Know

Albemarle is set to report its Q1 results next month, and analysts are projecting its EPS will climb in triple-digits.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Albemarle Stock: Is ALB Outperforming the Materials Sector?

Albemarle has outperformed its sector peers recently, and analysts remain moderately optimistic about the stock’s prospects.

Barchart

Is Albemarle Setting Up for a Lithium-Fueled Rebound?

Albemarle stock dipped after earnings, but rising lithium demand, particularly from AI-driven power needs could create a compelling long-term entry point

MarketBeat

What Are Wall Street Analysts' Target Price for Albemarle Stock?

As Albemarle has notably outpaced the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

These 3 Dividend Stocks Could Soar in 2026

After a volatile start to 2026, these three dividend stocks combine strong early momentum, analyst support, and income potential for the year ahead.

Barchart

MarketBeat Week in Review – 01/12 - 01/16

Economic data helped stocks move higher as it showed that the Fed's decision on interest rates may not interrupt the bullish case for equities in 2026.

MarketBeat

Albemarle’s Q4 2025 Earnings: What to Expect

Albemarle is set to report its Q4 results. Here’s what analysts are expecting prior to that from this outperforming stock.

Barchart

Albemarle Sits at the Center of Lithium’s Next Cycle

Albemarle stock surged in 2025, but analysts see further upside. Rising lithium prices, storage demand, and disciplined supply could shape ALB in 2026

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Albemarle Stock Outperforming the Dow?

Albemarle stock continues to run ahead of the Dow, supported by largely favorable analyst views.

Barchart

Albemarle Stock: Is Wall Street Bullish or Bearish?

Specialty chemical giant Albemarle has underperformed the broader market over the past year, and analysts remain cautious about the stock’s prospects.

MarketBeat

3 Signals Pointing to a Turnaround for Albemarle

Albemarle is strengthening its balance sheet with an asset sale as a wave of analyst upgrades suggests a potential recovery for the lithium leader.

Benzinga

Stock Of The Day: Trading Opportunities In Albemarle?

Albemarle Corporation (NYSE:ALB) is trading lower on Monday. The shares were up on Friday but, at last check on Monday, were down over 6.3%. This move followed positive comments and a new ‘buy' recommendation from a brokerage firm.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Albemarle Nets $660 Million From Asset Sales, Keeps Foot In Ketjen's Future

Albemarle Corporation (NYSE:ALB), a supplier of materials used in mobility, energy, connectivity, and health applications, has entered into a definitive agreement to sell a controlling interest in Ketjen Corporation’s refining catalyst solutions business to KPS Capital Partners, LP.

Benzinga

This Albemarle Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Barchart

Albemarle Earnings Preview: What to Expect

Albemarle is prepared to release its third-quarter results next month, with analysts predicting a significant double-digit earnings rise.

Benzinga

Stock Of The Day: Reversal Time For Albemarle?

Trading in Albemarle Corporation (NYSE:ALB) is quiet Friday. The stock has stalled at a resistance level.

MarketBeat

5 EV Battery and Lithium Stocks Charging the Future

The EV battery market is projected to exceed $250 billion by 2035, presenting investors with opportunities in both lithium giants and high-risk innovators.

MarketBeat

Lithium Americas Rally Lifts Other Rare Earth Stocks

Lithium Americas (LAC) surged 90% after a U.S. government stake fueled rare earth momentum, putting Albemarle (ALB) and Uranium Energy (UEC) on watch.

Benzinga

Abermarle Shares Are Trading Higher Wednesday: What's Going On?

Shares of Albemarle Corporation (NYSE:ALB) are trading higher Wednesday alongside several other lithium stocks after Lithium Americas Corp. (NYSE:LAC) surged on reports that the Trump administration is seeking an equity stake in the company.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.